Recombinant Human Cripto /hFC Protein
- 发布日期: 2024-02-01
- 更新日期: 2025-04-18
产品详请
产地 |
China
|
品牌 |
|
货号 |
B21815607
|
用途 |
Research Grade
|
包装规格 |
|
纯度 |
95%
|
CAS编号 |
|
是否进口 |
是
|
1.Alternative Name:TDGF1
2.Target:Cripto
3.Source:Human Cripto was expressed from HEK293 with human IgG1 FC at the C-terminal
4.Sequence:Leu31-Asp150
5.Protein structure::P13385hFC
6.Molecular Characterization:The protein has a calculated MW of 39kDa.The reducing (R) heterodimer protein migrates as 40-50 kDa due to glycosylation
7.Purity:SDS-PAGE>90%,SEC-HPLC>95%
8.Reconstitution:sterile H2O
9.Endotoxin:<1EU/mg
10Formulation:Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
11.SDS-PAGE
Determined by SDS-PAGE, the purity of the protein is greater than 90%.
12.SEC-HPLC
Determined by SEC-HPLC, the purity of the protein is greater than 95%.
13.ELISA
When Anti Human Cripto Antibody(clone B3F6) is immobilized at 2μg/mL (100 μL/well), the concentration of Recombinant Human Cripto /hFC Protein that produces 50% of the optimal binding response is approximately 0.1 ug/ml.
14.Note:For Research Use Only.